Technical Analysis for VRPX - Virpax Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 2.36 | 9.26% | 0.20 |
Earnings due: May 14
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New 52 Week Closing Low | Bearish | 9.26% | |
| 180 Bearish Setup | Bearish Swing Setup | 9.26% | |
| Outside Day | Range Expansion | 9.26% | |
| Wide Bands | Range Expansion | 9.26% | |
| Oversold Stochastic | Weakness | 9.26% | |
| NR7 | Range Contraction | 2.16% | |
| Narrow Range Bar | Range Contraction | 2.16% | |
| Wide Bands | Range Expansion | 2.16% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakout | about 12 hours ago |
| Rose Above Previous Day's High | about 12 hours ago |
| Up 10% | about 12 hours ago |
| Up 5% | about 12 hours ago |
| Up 3% | about 12 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/14/2024
Virpax Pharmaceuticals, Inc. Description
Virpax Pharmaceuticals, Inc. develops and manufactures non-opioid and non-addictive based drug compounds and drug delivery systems for pain management. It offers products, such as Probudur, an injectable bupivacaine hydrogel for postoperative pain management; Epoladerm, a diclofenac metered-dose spray film for acute musculoskeletal pain; and NES100, an endogenous enkephalin intranasal spray for acute and chronic spray. The company develops drug delivery technologies, such as Topical metered-dose spray, Liposomal in Hydrogel encapsulation, and Enkephalin Intranasal spray. It also develops therapies to manage post-traumatic stress disorder (PTSD), as well as to help prevent viral spread, including influenza and SARS-CoV-2 (Covid-19). Virpax Pharmaceuticals, Inc. was founded in 2016 and is based in Malvern, Pennsylvania.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Sciences Drugs Pain Euphoriants Opioids Influenza Pain Management Drug Delivery Analgesics Morphinans Post Traumatic Stress Disorder Drug Delivery Systems Heroin Bupivacaine Morphine Nasal Administration
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.774 |
| 52 Week Low | 2.105 |
| Average Volume | 28,932 |
| 200-Day Moving Average | 5.45 |
| 50-Day Moving Average | 3.58 |
| 20-Day Moving Average | 3.01 |
| 10-Day Moving Average | 2.53 |
| Average True Range | 0.35 |
| RSI (14) | 35.06 |
| ADX | 22.82 |
| +DI | 20.22 |
| -DI | 30.59 |
| Chandelier Exit (Long, 3 ATRs) | 3.00 |
| Chandelier Exit (Short, 3 ATRs) | 3.14 |
| Upper Bollinger Bands | 4.13 |
| Lower Bollinger Band | 1.90 |
| Percent B (%b) | 0.21 |
| BandWidth | 74.21 |
| MACD Line | -0.40 |
| MACD Signal Line | -0.32 |
| MACD Histogram | -0.0777 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.80 | ||||
| Resistance 3 (R3) | 2.79 | 2.64 | 2.72 | ||
| Resistance 2 (R2) | 2.64 | 2.53 | 2.64 | 2.70 | |
| Resistance 1 (R1) | 2.50 | 2.46 | 2.57 | 2.51 | 2.68 |
| Pivot Point | 2.35 | 2.35 | 2.39 | 2.35 | 2.35 |
| Support 1 (S1) | 2.21 | 2.24 | 2.28 | 2.21 | 2.04 |
| Support 2 (S2) | 2.06 | 2.17 | 2.06 | 2.02 | |
| Support 3 (S3) | 1.92 | 2.06 | 2.00 | ||
| Support 4 (S4) | 1.92 |
